China is determined to become a larger player in the pharmaceutical market, and offering more opportunities for cross-border collaboration.
In terms of cross-border collaboration in the pharmaceutical business, Dr. Francis Tse, CSO of Laboratory Testing Division at WuXi AppTec, said collaboration between the West and emerging markets, specifically China and India, are most noteworthy. "China is determined to be a major player," said Tse, noting the country's new set of drug approval policies. The Chinese government and the China Food and Drug Administration (CFDA) are starting an advisory committee, following an American example, Tse explained. China was also acknowledged as a regulatory member of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) in June of 2017.